معرفی
Linus Milinski is a Postdoctoral Research Scientist at the University of Oxford's Department of Physiology, Anatomy and Genetics (DPAG), affiliated with both the Molnar Group and Vyazovskiy Group. His research investigates cortical circuitry's role in sleep regulation and its interaction with phantom auditory perceptions like tinnitus, utilizing genetic manipulation, electrophysiological recordings, and computational analysis.
His academic journey includes a DPhil in tinnitus and sleep research from Oxford supervised by Victoria Bajo-Lorenzana, Vladyslav Vyazovskiy, and Fernando Nodal; an MSc project at the Max-Planck-Institute for Experimental Medicine under Livia de Hoz; and a BSc in Biology from Georg-August University Göttingen.
Milinski's work bridges fundamental neuroscience with clinical applications, focusing on how waking experiences modulate sleep pressure and how phantom sounds disrupt sleep architecture. His methodology integrates cross-species approaches from ferret tinnitus models to rodent behavioral paradigms, revealing meaning-dependent sound processing mechanisms during sleep.
Recent publications demonstrate consistent focus on neural mechanisms of sleep disruption by auditory stimuli, particularly tinnitus, alongside computational tool development for sleep analysis. This research trajectory connects basic cortical physiology with translational applications for sleep and auditory disorders.
Funded by Action on Hearing Loss for tinnitus research, Milinski actively contributes to science communication as editor of The Oxford Scientist and Events Lead for research.careers.org. He teaches neuroscience at Balliol College Oxford and the Oxford MSc Sleep Medicine course, extending his expertise to academic instruction and public engagement.
As part of DPAG—ranked #1 globally for Anatomy & Physiology—Milinski collaborates within Oxford's leading neuroscience ecosystem, contributing to the department's mission of reassembling physiological processes across molecular, cellular, and systems levels while interfacing with translational medicine initiatives.
